The addiction of melanomas to V600EBRAF appears to reflect a more general addiction to the RAS-BRAF-MEK-ERK pathway, as MEK inhibitors CI 1040, U0126, AZD6244 and trametinib also cause cell death [22-24]. Here, BRAF is linked to melanoma.